etrolizumab (RG7413) - Roche
Etrolizumab: Data from P3 LAUREL trial (NCT02165215) for ulcerative colitis in 2020 (Roche) - Sep 17, 2019 - Pharma Day 2019: Data from P3 GARDENIA trial (NCT02136069) for moderate to severe ulcerative colitis in 2020 
P3 data
https://www.roche.com/investors/agenda/roche-pharma-day-2019.htm
 
Sep 17, 2019
 
 
5d4a262a-b07c-47c7-b802-092918c1a218.jpg